NEOL BIO

Trading sesion


30/08/2017 Close

0.2500

Last price


2.31 mill. €

Capitalisation

-7.41

Dif.(%)


-78.81

% Year 2017

Suspended 26/09/2017

Last Trade

Last

0.2500

Ref.

0.2700

Dif.(%)

-7.41

Volume (Shares)

8,397

Turnover (€x1000)

2.16

Security

Security name

NEOL BIOSOLUTIONS

Ticker

NEOL

ISIN

ES0105081006

NIF

A-18997627

Capital Admitted

4.435.920,00 Euros

Shares Admitted

9.241.500

Nominal

0,48 Euros

Trading

Fixing

Liquidity Provider

MERCADOS Y GESTIÓN DE VALORES A.V., S.A.

Registered Advisor

GVC Gaesco Beka, S.V., S.A.

Auditor

DELOITTE, S.L

Address

CL/ BLANCA DE NAVARRA 7, 28010 MADRID

Contact

accionistas@neolbio.com

Historical Summary

 201520162017 until 15/12

Capital Admitted (thousands of euros)

4,4364,4364,436

Shares (x 1,000)

9,2429,2429,242

Period Close Price (euros)

1.37001.18000.2500

Period Last Price (euros)

1.37001.18000.2500

Period High Price (euros)

1.90001.51001.3000

Period Low Price (euros)

1.26000.96000.2500

Capitalisation (thousands of euros)

12,66110,9052,310

Volume (thousands of shares)

6771,5501,039

Turnover (thousands of euros)

1,1101,8701,175

Company Profile

Neol Bio, a subsidiary of Neuron Bio is devoted to the development of innovative processes within the microbial industrial biotechnology for its application in oleochemical, bioenergy and biopolymer sectors. 

Due to the use of advanced molecular biology techniques, bioprocess engineering and industrial microbiology, Neol achieves economically viable bioprocesses, thus reducing the use of chemical contaminates and assessing agricultural and industrial waste. 

Neol has facilities, laboratories and cutting-edge equipment in the biotechnology field, as well as an own pilot plant for demonstration of the processes it develops. 

Neol has a team of over 30 high qualified researchers, such as microbiologists, molecular biologists, experts in analytical chemistry and bioprocesses engineers with renowned prestige in the sector, who participate actively in numerous scientific projects. 

Its headquarters in Madrid and main facilities are located in the Granada Health Sciences Technology Park.

Relevant Facts and Notices

Photo Gallery

To obtain detailed information or information in other formats, please contact BME Market Data at marketdata@grupobme.es or visit the website www.bmemarketdata.es.

The information provided by the different websites of Grupo BME is for internal use only. For any commercial use and/or other usage that involves the redistribution of the information to third parties, it is required a prior and express permission from BME Market Data. Please contact us at marketdata@grupobme.es.

MARKET STATUS

If an issue occurs, the message "TRADING" will change to "MARKET ISSUE" to reflect that a market event has occurred. By clicking on the Issue of the published alert it will be possible to access the information and intraday updates associated with this incident, which will be published immediately.

Note: BME will use its discretion to assign the severity of an incident